Next report date
Report period
Q2 2024
EPS estimate
0.06EUR
Revenue estimate
—
0.32EUR
519.84 MEUR
9.64 BEUR
219.90 M
About GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Sector
CEO
Hong Li
Headquarters
Guangzhou
Website
Employees (FY)
28.05 K
Founded
1997
ISIN
CNE100000387
FIGI
BBG000BGYYR0
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GUANG.BAIY.PHAR.HO.H YC 1 stocks are traded under the ticker GU5.
GUANG.BAIY.PHAR.HO.H YC 1 is going to release the next earnings report on Aug 18, 2024. Keep track of upcoming events with our Earnings Calendar.
GU5 earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.04 EUR resulting in a −52.94% surprise. The estimated earnings for the next quarter are 0.09 EUR per share. See more details about GUANG.BAIY.PHAR.HO.H YC 1 earnings.
GUANG.BAIY.PHAR.HO.H YC 1 revenue for the last quarter amounts to 2.52 B EUR despite the estimated figure of 3.04 B EUR. In the next quarter revenue is expected to reach 1.81 B EUR.
Yes, you can track GUANG.BAIY.PHAR.HO.H YC 1 financials in yearly and quarterly reports right on TradingView.
GU5 net income for the last quarter is 252.23 M EUR, while the quarter before that showed 33.16 M EUR of net income which accounts for 660.69% change. Track more GUANG.BAIY.PHAR.HO.H YC 1 financial stats to get the full picture.
Yes, GU5 dividends are paid annually. The last dividend per share was 0.10 EUR. As of today, Dividend Yield (TTM)% is 3.81%. Tracking GUANG.BAIY.PHAR.HO.H YC 1 dividends might help you take more informed decisions.
GUANG.BAIY.PHAR.HO.H YC 1 dividend yield was 3.44% in 2023, and payout ratio reached 27.17%. The year before the numbers were 3.53% and 28.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GU5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUANG.BAIY.PHAR.HO.H YC 1 stock right from TradingView charts — choose your broker and connect to your account.
As of May 4, 2024, the company has 28.05 K employees. See our rating of the largest employees — is GUANG.BAIY.PHAR.HO.H YC 1 on this list?
We've gathered analysts' opinions on GUANG.BAIY.PHAR.HO.H YC 1 future price: according to them, GU5 price has a max estimate of 3.11 EUR and a min estimate of 3.10 EUR. Watch GU5 chart and read a more detailed GUANG.BAIY.PHAR.HO.H YC 1 stock forecast: see what analysts think of GUANG.BAIY.PHAR.HO.H YC 1 and suggest that you do with its stocks.